Latest 8-K filings

RadNet, Inc. has filed a prospectus supplement to register for resale up to 34,069 shares of its common stock by certain See-Mode Sellers, stemming from a June 2025 Share Purchase Agreement.

Elme Communities has completed the sale of its Elme Bethesda property for $58.0 million, as part of its ongoing liquidation and asset disposition strategy.

BioRestorative Therapies, Inc. has immediately suspended all orders and shipments of its biocosmeceutical product lines, ExoCR and BioX, pending a business review and regulatory assessment.

Enveric Biosciences reported second quarter 2026 financial results and provided a corporate update, highlighting advancements in its EB-003 development program and securing new patents.

Reeds, Inc. received a deficiency notice from NYSE American for failing to meet continued listing standards regarding stockholder equity, though a compliance plan has been accepted.

Barfresh Food Group reported a 190% year-over-year revenue increase to $4.7 million in Q2 2026, driven by the Arps Dairy acquisition, but revised full-year guidance downwards due to production inefficiencies.

Greenlane Holdings reported a significant net loss and a sharp year-over-year revenue decrease in its second quarter 2026 results, while its digital asset holdings saw a substantial decline in fair value.

VICI Properties L.P. has completed the offering of $900 million in 5.400% Senior Notes due 2031 and $850 million in 5.750% Senior Notes due 2036, intending to use proceeds to repay existing debt.

Martin Marietta Materials announces the issuance of $5.5 billion in senior notes across five series to fund its acquisition of Lhoist North America, Inc.

Vycor Medical, Inc. announced financial results for the three and six months ended June 30, 2026, showing a decrease in revenue and operating profit for its Vycor Medical division.

SES AI Corporation received notice from the NYSE of its intent to delist the company's public warrants due to abnormally low selling prices.

NewAmsterdam Pharma Company N.V. amends prior filing to detail separation and advisory agreements for former COO Douglas Kling.

LeonaBio announced its second quarter 2026 financial results, highlighting progress in its Phase 3 ELAINE-3 trial for lasofoxifene and providing a business update.

SkinHealth Systems Inc. announced the resignation of its Chief Operations, Quality and Technology Officer, Sheri Lewis, effective August 28, 2026.

O'Reilly Automotive, Inc. has announced the issuance of $1.6 billion in aggregate principal amount of new senior notes across three tranches maturing in 2029, 2031, and 2037.

Prestige Consumer Healthcare Inc. announced the retirement of Senior Vice President, Operations, Jeffrey Zerillo, effective August 14, 2026.

Carlyle Credit Income Fund announced its unaudited net asset value per common share as of July 31, 2026, was $3.24.

CSP Inc. announced its third quarter fiscal year 2026 financial results, reporting a decrease in sales and an increased net loss, though highlighting a strong backlog and optimism for fiscal year 2027.

Lifeloc Technologies announced second quarter 2026 results, showing a 10% increase in net revenue to $2.445 million and improved gross margins, though the company reported a net loss of $134,000.

BioForce NanoScience Holdings, Inc. has announced several key appointments to its leadership and advisory teams, including a new General Counsel, a new Director, and two Advisory Board members, effective May and June 2026.

HCW Biologics Inc. announced its second quarter 2026 financial results, highlighting positive preliminary data for its HCW9302 drug candidate and significant revenue growth, while also addressing ongoing financial challenges.

Reading International announced robust second quarter 2026 results, showcasing significant revenue and income growth driven by strong cinema operations and favorable foreign exchange rates.

AppTech Payments Corp. has entered into a $500,000 promissory note with the Suzanne D. Lord Spousal Estate Reduction Trust for working capital, with a 9.0% interest rate and a 90-day maturity.

Emmaus Life Sciences announces a 124% surge in Q2 2026 net revenues, primarily from a new license agreement, alongside reduced operating expenses and a return to profitability.

HCW Biologics Inc. announced that its previously issued unaudited condensed financial statements for the three months ended March 31, 2026, should no longer be relied upon due to an error in earnings per share calculation.

StoneBridge Acquisition II Corporation has entered into a waiver agreement with Scieniti LLC, irrevocably waiving administrative service fees from October 1, 2025, through its initial business combination or liquidation.

Lion Copper and Gold Corp. provided an update on its Yerington Copper Project, confirming progress on the Definitive Feasibility Study and permitting activities, with completion of the DFS expected in Q1 2027.

Qrons Inc. provided a Q2 2026 shareholder update detailing operational progress, product launches, and a multi-step plan to address reporting deficiencies and improve market quotation status.

Bluerock Homes Trust, Inc. reports the payment of a portion of its Q2 2026 base management fee in C-LTIP Units to executives, aligning interests and reducing cash expenditures.

Creatd, Inc. has regained its SEC reporting status and filed its Q2 2026 report, showcasing a substantially rebuilt balance sheet with positive working capital.